Mobia Medical Appoints Myriam Curet, M.D. to its Board of Directors
Mobia Medical, Inc. has announced the appointment of Myriam Curet, M.D., to the Board as an independent director, effective July 30, 2026.
“We are thrilled Myriam will be joining the Mobia Medical Board of Directors,” said Richard Foust, President and Chief Executive Officer of Mobia Medical. “Her decades long clinical and executive leadership at Intuitive Surgical paired with her ongoing surgical practice and public company board experience bring a unique combination of medical and corporate governance expertise to Mobia’s Board. Her lifelong commitment to patient-centered innovation and her perspective of what it takes to translate scientific advancement into meaningful clinical impact will be a key asset to the Company.”
Dr. Curet has served as a Clinical Professor of Surgery at Stanford University School of Medicine since 2015 and previously held a series of faculty positions in Stanford’s Department of Surgery from 2000 to 2015, most recently as Professor of Surgery. She has also held a part-time clinical appointment at the Palo Alto Veterans Administration Medical Center since October 2010. Earlier in her career, she was an Associate Professor of Surgery at the University of New Mexico from 1994 to 2000 and held positions with the Indian Health Service, including as Deputy Medical Director of the Gallup Indian Medical Center in New Mexico.
“I have spent my career as a surgeon working with innovative medical technology companies, and I have seen firsthand what it means for a breakthrough technology to change the paradigm in standard of care,” said Dr. Curet. “I am excited to join the Mobia Medical Board and to support the company as we scale the business, expand access to Vivistim, and improve the lives of stroke survivors on their recovery journey.”
Dr. Curet currently serves on the board of directors of Inspire Medical Systems (NYSE: INSP), a medical technology company focused on obstructive sleep apnea and Stereotaxis (NYSE American: STXS), a robotic technology company for the treatment of cardiac arrhythmias. She previously served as a director of Nektar Therapeutics, a public biopharmaceutical company, from December 2019 to June 2024. Dr. Curet received her B.A. from Bryn Mawr College and her M.D. from Harvard Medical School, completed her general surgery residency at the University of Chicago and a fellowship in surgical endoscopy at the University of New Mexico, and is a Fellow of the American College of Surgeons.
Source: Mobia Medical, Inc.